PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
23467537-10	2011	After treatment with PS-341, a proteasome inhibitor, the IkappaB degradation was inhibited, IkappaB expression increased, NF-kappaB and P-gp expression decreased in a time dependent manner.	Bortezomib	21-27	nuclear factor kappa B subunit 1	Homo sapiens	122-131	
23467537-11	2011	Compared to DNR group, the NF-kappaB p65 activity of DNR+PS-341 group was decreased.	Bortezomib	57-63	nuclear factor kappa B subunit 1	Homo sapiens	27-36	
23467537-14	2011	The mechanism may be that bortezomib decreases the degradation of IkappaB and the expression of NF-kappaB and P-gp, therefore induces the apoptosis of multi-drug resistant cells.	Bortezomib	26-36	nuclear factor kappa B subunit 1	Homo sapiens	96-105